• >
  • >
  • >
  • >
  • >
Upload Avatar (500 x 500)
Xin Feng Liu
Mayo Clinic College of Medicine
University of Science and Technology of China
Anhui
Language: English, Chinese
Contact
Cerebrovascular Diseases Interventional Treatment Clinical Applications Artificial Intelligence Cerebral Hemodynamics Translational Medicine Neurology Research Clinical Trials Medical Innovation
Areas of Focus
  • Clinical and interventional treatment of cerebrovascular diseases
  • Artificial intelligence in cerebral hemodynamics and clinical applications
  • Translational medicine for neurological diseases
Work Experience
  • 2002-present - Nanjing University Neurology Institute - Director/Professor/Chief Physician
  • 2018-present - First Affiliated Hospital of USTC/Clinical Medical College - Vice President/Professor/Chief Physician
Academic Background & Achievements
  • 1982-1987 Bachelor: Second Military Medical University, Clinical Medicine
  • 1988-1991 Master: Second Military Medical University, Neurology
  • 1998-2001 PhD: University of Lausanne, Neurology
  • 2001-2002 Postdoc: University of Minnesota, Alzheimer's Research Center
  • Achievement: Over 300 SCI papers published as first or corresponding author
  • Achievement: Received National Science and Technology Progress Award (Second Prize) in 2014
Publications
  • Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion, Tao C, Nogueira RG, Zhu Y, Sun J, Han H, Yuan G, Wen C, Zhou P, Chen W, Zeng G, Li Y, Ma Z, Yu C, Su J, Zhou Z, Chen Z, Liao G, Sun Y, Ren Y, Zhang H, Chen J, Yue X, Xiao G, Wang L, Liu R, Liu W, Liu Y, Wang L, Zhang C, Liu T, Song J, Li R, Xu P, Yin Y, Wang G, Baxter B, Qureshi AI, Liu X (Corresponding Author), Hu W; ATTENTION Investigators, 2022
  • Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial, Liu X (Corresponding Author), Dai Q, Ye R, Zi W, Liu Y, Wang H, Zhu W, Ma M, Yin Q, Li M, Fan X, Sun W, Han Y, Lv Q, Liu R, Yang D, Shi Z, Zheng D, Deng X, Wan Y, Wang Z, Geng Y, Chen X, Zhou Z, Liao G, Jin P, Liu Y, Liu X, Zhang M, Zhou F, Shi H, Zhang Y, Guo F, Yin C, Niu G, Zhang M, Cai X, Zhu Q, Chen Z, Liang Y, Li B, Lin M, Wang W, Xu H, Fu X, Liu W, Tian X, Gong Z, Shi H, Wang C, Lv P, Tao Z, Zhu L, Yang S, Hu W, Jiang P, Liebeskind DS, Pereira VM, Leung T, Yan B, Davis S, Xu G, Nogueira RG; BEST Trial Investigators, 2020
  • Dietary Fiber Intake Reduces Risk for Gastric Cancer: a Meta-Analysis, Zhang ZZ, Xu GL, Ma MM, Yang J, Liu XF (Corresponding Author), 2013
  • Aberrant oligodendroglial LDL receptor orchestrates demyelination in chronic cerebral ischemia, Xie Y, Zhang X, Xu P, Zhao N, Zhao Y, Li Y, Hong Y, Peng M, Yuan K, Wan T, Sun R, Chen D, Xu L, Chen J, Guo H, Shan W, Li J, Li R, Xiong Y, Liu D, Wang Y, Liu G, Ye R, Liu X (Corresponding Author), 2021
  • Vascular endothelium deploys caveolin-1 to regulate oligodendrogenesis after chronic cerebral ischemia in mice, Zhao Y, Zhu W, Wan T, Zhang X, Li Y, Huang Z, Xu P, Huang K, Ye R, Xie Y, Liu X (Corresponding Author), 2022
  • Astrocytic phagocytosis contributes to demyelination after focal cortical ischemia in mice, Wan T, Zhu W, Zhao Y, Zhang X, Ye R, Zuo M, Xu P, Huang Z, Zhang C, Xie Y, Liu X (Corresponding Author), 2022
  • Genetically Predicted Smoking and Alcohol Consumption and Functional Outcome After Ischemic Stroke, Zhang Z, Wang M, Gill D, Liu X (Corresponding Author), 2022
  • A Nomogram for Predicting Stroke Recurrence Among Young Adults, Yuan K, Chen J, Xu P, Zhang X, Gong X, Wu M, Xie Y, Wang H, Xu G, Liu X (Corresponding Author), 2020
Awards
  • 2014: National Science and Technology Progress Award (Second Prize)
  • 2013: Jiangsu Province Science and Technology Progress Award (First Prize)
  • 2011: Ministry of Education Science and Technology Progress Award (First Prize)
Post a Project

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that AGP may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from AGP.
Submit

Thank you for your message!
We will contact you soon.